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Aim of presentation
 To explore the difficulties associated with the diffusion 
of needle exchange provision for injecting drug users 
across the Irish healthcare system, while setting this 
exploration in the wider context of the harm reduction 
movement both  nationally and globally 
The historical background 
 Injecting drug use was virtually unknown in Ireland  
until Dublin’s  ‘opiate epidemic’ 0f 1979-1983
 This was rapidly followed by the advent of HIV and the 
realization that this new virus was being transmitted 
through equipment sharing between injecting drug 
users 
 Prior to this, all Irish drug treatment systems were 
geared towards abstinence  - so that healthcare and 
criminal justice sectors were of one mind on the ideal 
of promoting a drug-free lifestyle   
Harm Reduction Internationally
 Some countries had previous experience of harm 
reduction, e.g. ‘the British system’ (1928-1968), or the 
Dutch system from 1976 onwards
 Harm reduction challenged the main negative  stereotypes 
of drug users – utterly deviant and  incapable of rational 
behaviour
 It legitimized healthcare interventions aimed at reducing 
drug-related damage, without necessarily having 
abstinence as their ultimate goal
 For heroin users methadone maintenance became the 
standard form of harm reduction, but all for injecting drug 
users needle exchange was another strategy commonly 
mooted- not just for HIV but also for HBC prevention 
Controversy about Harm Reduction 
 With few exceptions, most countries experienced 
public controversy about the morality of harm 
reduction – condoning and facilitating illegal and 
immoral acts?
 The public health pragmatism of harm reduction did 
not convince all those involved in drug policy – who 
tended to see specific harm reduction practices as ‘the 
thin end of the wedge’
 Critics frequently hedged their bets – ‘it compromises 
our shared values about the evils of drug and it doesn’t 
work’ 
Needle exchange as harm 
reduction 
 The phrase conventionally refers to programmes which 
offer injecting drug users clean needles and syringes  (plus 
additional paraphernalia) and health education/promotion 
- all with a view to preventing the spread of blood-borne 
viruses
 Technically, the evidence is clear on the value of needle 
exchange in preventing HIV transmission, but much less 
clear on its value in relation to HCV
 To its critics, the research evidence demonstrates that 
needle exchange is a failure; to its supporters, the evidence 
suggests the necessity to expand provision and make it 
more accessible
Harm Reduction in Ireland
 Butler and Mayock (2005) argued that the main defining 
feature of Ireland’s introduction of harm reduction was the 
covert, incremental nature of the policy process and its 
overall ambiguity- relatively little public debate and no 
explicit announcement of the replacement of abstinence as 
a policy goal
 This argument, while not seeing Irish political culture as 
unique, suggested that the divisive nature of public debates 
on divorce and abortion during the 1980s put politicians off 
a national debate on harm reduction
 If we had a national debate and a referendum now (2009) 
on needle exchange, how would it go?   
Drug Policy Documents and Needle 
Exchange
 Government Strategy to Prevent Drug Misuse (1991) contained no 
reference to needle exchange, despite the fact that needle exchange 
had been available in Dublin from the Eastern Health Board’s AIDS 
Resource Centre at Baggot St., Dublin
 The First Report of the Ministerial Task Force on Measures to Reduce 
the Demand for Drugs (Rabbitte Report) (1996) contained no 
reference to needle exchange
 Building on Experience: National Drugs Strategy 2001-2008 had 
minimal reference to topic, but one ‘action’ called for review of 
availability and another for pilot community pharmacy needle 
exchange scheme
 National Drugs Strategy 2009-2016 noted limited availability (in 5 
out of 10 RDTFs and 13 out of 14 LDTFs), but announced that the 
community pharmacy scheme would start with funds from Elton 
John Foundation
Needle exchange in Ireland: the 
present position
 Excellent review (Cox and Robinson, 2008) published 
by NDST/NACD clarifying regional variations in 
needle exchange provision
 Nonetheless, it seems that provision is most developed 
in those areas with the highest prevalence of injecting 
drug use
 Urban centres outside of Dublin and rural areas 
generally still have a low incidence / prevalence of 
injecting heroin use (and a still lower rate of injecting 
cocaine use) – confirmed in reports from National 
Drug Treatment Reporting System
Diffusing needle exchange to rural 
Ireland: ideological issues
 Needle exchange, in the words of Michael McDowell, is an 
example of ‘moral fuzziness’; and is deeply offensive to the 
sensibilities of many Irish citizens
 It does not have the moral or ideological neutrality of most 
health interventions, and perhaps its promoters should 
remember this – especially in recessionary times
 Drug injectors as health service users continue to be a 
stigmatized group,  and aggressive public opposition to the 
siting of services (the NIMBY factor) remains a constant 
threat
 How publicly and explicitly should the case for needle 
exchange diffusion be presented?   
Diffusing needle exchange to rural 
Ireland: logistical issues
 Because of the relatively small numbers of drug  
injectors in rural areas and provincial towns, centre-
based needle exchanges are impractical
 Vending machines have advantages but also many 
disadvantages – e.g.  high visibility 
 Outreach services – workers and mobile units offer 
flexibility and have many advantages
 Community pharmacy schemes, on balance, seem to 
have many advantages, but need to be supported and 
evaluated in areas with a low density of injectors
Conclusion 
 The evidence for the use of needle exchange is generally supportive of 
its value in reducing transmission of blood-borne viruses, and in 
Ireland the high prevalence of HBC infection amongst drug injectors 
makes its use all the more compelling
 Nonetheless, policy and practice is bedevilled by wider controversies 
about ‘wars on drugs’ and continuing moral unease about service 
provision which appears to ‘trap’ its clients in  lifelong drug 
dependency
 Ideally, from a public health perspective, one would like to see its use 
strengthened in urban areas which have the greatest density of drug 
injectors, but it would also seem important to make it accessible to 
drug injectors all over Ireland – whether in rural districts, provincial 
towns or cities outside the Greater Dublin Area
 Such diffusion should take into consideration the ideological and 
logistical issues already mentioned here
